Stockscreener 앱 받기
74.21
0.60%
0.44
시간 외 거래:
74.21
전일 마감가:
$73.77
열려 있는:
$73.93
하루 거래량:
573.14K
Relative Volume:
1.03
시가총액:
$3.57B
수익:
$1.36B
순이익/손실:
$123.81M
주가수익비율:
30.79
EPS:
2.41
순현금흐름:
$20.35M
1주 성능:
-0.55%
1개월 성능:
+4.40%
6개월 성능:
+1.17%
1년 성능:
-17.77%
1일 변동 폭
$73.28
$75.44
1주일 범위
$72.06
$75.44
52주 변동 폭
$55.30
$94.98
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
HAE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
74.21 | 3.58B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-06-26 | 개시 | Robert W. Baird | Outperform |
| 2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 개시 | JP Morgan | Overweight |
| 2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 개시 | CL King | Buy |
| 2024-09-11 | 개시 | BofA Securities | Neutral |
| 2024-09-10 | 개시 | BTIG Research | Buy |
| 2024-06-12 | 업그레이드 | Needham | Hold → Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-08-17 | 재개 | Raymond James | Outperform |
| 2021-06-17 | 개시 | Citigroup | Buy |
| 2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 개시 | Needham | Buy |
| 2019-08-07 | 재확인 | Barrington Research | Outperform |
| 2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 재확인 | Barrington Research | Outperform |
| 2018-08-09 | 재확인 | Barrington Research | Outperform |
| 2018-02-07 | 재확인 | Barrington Research | Outperform |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 재확인 | Barrington Research | Outperform |
| 2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 재확인 | The Benchmark Company | Hold |
| 2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-08-02 | 재확인 | Jefferies | Buy |
| 2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
What drives Haemonetics Corporation stock priceTriple-digit return opportunities - jammulinksnews.com
Haemonetics Corporation Stock Analysis and ForecastFree Capital Allocation Plans - jammulinksnews.com
Why Haemonetics Corporation stock attracts strong analyst attentionFree Expert Investment Advice - Newser
Is Haemonetics Corporation a good long term investmentHigh-margin investment plays - jammulinksnews.com
What analysts say about Haemonetics Corporation stockOutstanding capital growth - jammulinksnews.com
Nisa Investment Advisors LLC Has $50,000 Position in Haemonetics Corporation (NYSE:HAE) - Defense World
Is Haemonetics Corporation stock a growth or value playMulti Bagger Alerts - Newser
What makes Haemonetics Corporation stock price move sharplyBig Return Stock Tips - Newser
How Haemonetics Corporation stock performs during market volatilityHigh Win Rate Stock Ideas - Newser
Platelet Aggregation Devices Market Set to Witness Significant - openPR.com
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know - Yahoo Finance
Haemonetics Announces Q1 FY26 Earnings Release and Conference Call - AInvest
Haemonetics Shares Rise After Upgrade From Citigroup - MarketScreener
Citi adjusts MedTech outlook: Bullish on Haemonetics, bearish on Tandem Diabetes - Investing.com
Haemonetics (NYSE:HAE) Coverage Initiated by Analysts at Robert W. Baird - Defense World
Analyst Baird Initiates Coverage on Haemonetics (HAE) with Outperform Rating | HAE Stock News - GuruFocus
Baird initiates Haemonetics stock with outperform rating on market position - Investing.com
Private cloud, AI compute markets continue to gain momentum - SiliconANGLE
Kalkine: Haemonetics (NYSE:HAE) Reflects Unique Sector Metrics in the russell 1000 - Kalkine Media
Haemonetics at Goldman Sachs Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Blood Platelets Market Deep Research Report with Forecast - openPR.com
Haemonetics at Goldman Sachs Conference: Strategic Growth and Challenges - Investing.com
Transcript : Haemonetics Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener
Zacks Research Decreases Earnings Estimates for Haemonetics - Defense World
Q3 EPS Estimates for Haemonetics Decreased by Zacks Research - Defense World
Are Investors Undervaluing Haemonetics Corporation (NYSE:HAE) By 36%? - Yahoo Finance
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference - Quantisnow
Haemonetics (HAE) – Investment Analysts’ Recent Ratings Updates - Defense World
Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus
HAEMONETICS CORP SEC 10-K Report - TradingView
JMP maintains Haemonetics stock $100 target post-results By Investing.com - Investing.com Canada
What 4 Analyst Ratings Have To Say About Haemonetics - Benzinga
Haemonetics (HAE) Stock Rating and Price Target Reaffirmed by JMP Securities | HAE Stock News - GuruFocus
JMP maintains Haemonetics stock $100 target post-results - Investing.com
Haemonetics Co. (NYSE:HAE) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Haemonetics Corporation (NYSE:HAE) Q4 2025 Earnings Call Transcript - Insider Monkey
HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up - Yahoo Finance
Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World
Haemonetics Corporation Just Beat EPS By 8.7%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Haemonetics Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Here's What Key Metrics Tell Us About Haemonetics (HAE) Q4 Earnings - Yahoo Finance
Raymond James Reiterates Strong Buy on Haemonetics (HAE) with Lo - GuruFocus
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.64%
0.34%
자본화:
|
볼륨(24시간):